Could paraprobiotics be a safer alternative to probiotics for managing cancer chemotherapy-induced gastrointestinal toxicities?

por Nobre, L.M.S., Fernandes, C., Florêncio, K.G.D., Alencar, N.M.N., Wong, D.V.T., Lima-Júnior, R.C.P.
Publicado 2023

Amifostine protects from the peripheral sensory neuropathy induced by oxaliplatin in mice

por Pereira, A.F., Lino, J.A., Alves, B.W.F., Lisboa, M.R.P., Pontes, R.B., Leite, C.A.V.G., Nogueira, R.B., Lima-Júnior, R.C.P., Vale, M.L.
Publicado 2020

IL-33 targeting attenuates intestinal mucositis and enhances effective tumour chemotherapy in mice

por Guabiraba, R, Besnard, A G, Menezes, G B, Secher, T, Jabir, M S, Amaral, S S, Braun, H, Lima-Junior, R C P, Ribeiro, R A, Cunha, F Q, Graham, G J, Teixeira, M M, Beyaert, R, Liew, F Y
Publicado 2014

Amifostine reduces inflammation and protects against 5-fluorouracil-induced oral mucositis and hyposalivation

por Barbosa, S.C.M., Pereira, V.B.M., Wong, D.V.T., Santana, A.P.M., Lucetti, L.T., Carvalho, L.L., Barbosa, C.R.N., Callado, R.B., Silva, C.A.A., Lopes, C.D.H., Brito, G.A.C., Alencar, N.M.N., Lima-Júnior, R.C.P.
Publicado 2019